Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

5(38%)

Results Posted

67%(2 trials)

Phase Distribution

Ph not_applicable

38%

Ph phase_1

15%

Ph phase_3

Ph phase_2

38%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution13 total trials

Phase 1Safety & dosage

2(15.4%)

Phase 2Efficacy & side effects

5(38.5%)

Phase 3Large-scale testing

1(7.7%)

N/ANon-phased studies

5(38.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(8)

Completed(3)

Terminated(1)

Other(1)

Detailed Status

Recruiting5

Completed3

Not yet recruiting3

unknown1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 12 (15.4%)

Phase 25 (38.5%)

Phase 31 (7.7%)

N/A5 (38.5%)

Trials by Status

unknown18%

completed323%

withdrawn18%

not_yet_recruiting323%

recruiting538%

Recent Activity

5 active trials

Showing 5 of 13

not_yet_recruitingnot_applicable

Impact of a Reminder App on Physical Activity During Radiation Therapy for Lung Cancer

NCT07627022

not_yet_recruitingphase_2

Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.

NCT07594431

recruitingnot_applicable

Precision Radiotherapy Enabled by Molecular MRI

NCT07512154

recruitingphase_1

NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma

NCT06012695

recruitingphase_3

Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma

NCT06706401

View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials

NCT07627022Not Applicable

Impact of a Reminder App on Physical Activity During Radiation Therapy for Lung Cancer

Not Yet Recruiting

NCT07594431Phase 2

Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.

Not Yet Recruiting

NCT07512154Not Applicable

Precision Radiotherapy Enabled by Molecular MRI

Recruiting

NCT06012695Phase 1

NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma

Recruiting

NCT06706401Phase 3

Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma

Recruiting

NCT06102057Phase 2

PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC

Recruiting

NCT07043543Not Applicable

Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11)

Not Yet Recruiting

NCT06276946Not Applicable

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia

Withdrawn

NCT06761937Phase 1

Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients

Recruiting

NCT03750539Not Applicable

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer

Unknown

NCT02336165Phase 2

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Completed

NCT02107430Phase 2

Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer

Completed

NCT00796718Phase 2

A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal Cancer

Completed

All 13 trials loaded

Drug Details

Intervention Type: RADIATION
Total Trials: 13